0001104659-18-000924.txt : 20180105 0001104659-18-000924.hdr.sgml : 20180105 20180105130923 ACCESSION NUMBER: 0001104659-18-000924 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180103 FILED AS OF DATE: 20180105 DATE AS OF CHANGE: 20180105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAPIRSTEIN JAMES CENTRAL INDEX KEY: 0001559509 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36856 FILM NUMBER: 18512816 MAIL ADDRESS: STREET 1: 1517 SAN JACINTO CITY: HOUSTON STATE: TX ZIP: 77002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ContraVir Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 4 1 a4.xml 4 X0306 4 2018-01-03 0 0001583771 ContraVir Pharmaceuticals, Inc. CTRV 0001559509 SAPIRSTEIN JAMES C/O CONTRAVIR PHARMACEUTICALS, INC. 399 THORNALL STREET, FIRST FLOOR EDISON NJ 08837 1 1 0 0 Chief Executive Officer Common Stock 2018-01-03 4 A 0 322092 0 A 492819 D The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person. /s/ James Sapirstein 2018-01-05